<DOC>
	<DOCNO>NCT01699581</DOCNO>
	<brief_summary>Nestle Impact show efficacy multiple surgical trial relation improve hospital length stay infection rate . 1 dose Nestle Impact Advanced Recovery take orally three time day begin morning follow stem cell transplant continue day hospital discharge .</brief_summary>
	<brief_title>Assessment Impact Nutritional Program During Autologous Stem Cell Transplant</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<criteria>Patients receive autologous stem cell transplant use preparative regimen BEAM ( Carmustine , Etoposide , Cytarabine , Melphalan ) , Melphalan 140mg/m2 , Melphalan 200mg/m2 Any prior diet supplement allow . Age &gt; 18 year . Ability understand willingness sign write informed consent document . History allergic reaction attribute compound similar chemical biologic composition Nestle Impact include fish oil .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Hodgkin 's Lymphoma</keyword>
	<keyword>Multiple Myeloma</keyword>
	<keyword>Non-Hodgkin 's Lymphoma</keyword>
</DOC>